文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

严重急性呼吸综合征冠状病毒2感染需气管切开患者的一年结局

One-Year Outcomes of Patients Requiring Tracheostomy Placement Due to Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
PubMed 文献 · Crit Care Explor · 2023-08-02
一句话结论因SARS-CoV-2感染需气管切开的ARDS患者,90天死亡率为29.9%、1年死亡率为44.5%,43.3%的幸存者1年后在家中生活。

这项回顾性随访队列研究纳入2020年3月至2021年3月间在大型医疗系统ICU因SARS-CoV-2感染相关ARDS而接受气管切开的164例连续成人患者,平均年龄63.5岁,66.5%为男性。住院期间常见并发症包括谵妄、继发感染、急性肾损伤、气胸和静脉血栓栓塞。90天和1年死亡率分别为29.9%和44.5%;58.5%的患者脱离呼吸机,51.2%拔除气管套管。哮喘、COPD、心房颤动和ICU内需肾脏替代治疗与呼吸机依赖风险增加相关。1年幸存者中43.3%在家中、12.2%在专业护理机构。作者认为超过90天的长期照护支持(包括气管切开)似乎有益,值得进一步研究。

要点

  • 因SARS-CoV-2感染需气管切开的ARDS患者90天死亡率为29.9%,1年死亡率为44.5%。
  • 58.5%的患者脱离呼吸机,51.2%的患者拔除气管套管。
  • 哮喘、COPD、心房颤动和ICU内需肾脏替代治疗与呼吸机依赖风险增加相关。
  • 1年幸存者中43.3%在家中、12.2%在专业护理机构。
  • 作者认为超过90天的长期照护支持(包括气管切开)似乎有益,值得进一步研究。

适用人群与场景

  • 2020年3月至2021年3月间在大型医疗系统ICU因SARS-CoV-2感染相关ARDS而接受气管切开的164例连续成人患者。

研究设计与关键结果

  • 研究类型:回顾性随访队列研究;样本量164例连续患者;人群:因SARS-CoV-2感染相关ARDS入住ICU并需气管切开的成人;平均年龄63.5岁,男性109例(66.5%)。
  • 常见合并症:肥胖、高血压、糖尿病、充血性心力衰竭、慢性肾脏病、慢性阻塞性肺疾病(COPD)、心房颤动和哮喘。
  • 住院期间常见并发症:谵妄、继发感染、急性肾损伤、气胸和静脉血栓栓塞。
  • 90天死亡率为29.9%,1年死亡率为44.5%。
  • 96例(58.5%)脱离呼吸机,84例(51.2%)拔除气管套管。
  • 哮喘、COPD、心房颤动和ICU内需肾脏替代治疗与呼吸机依赖风险增加相关。
  • 1年幸存者中,71例(43.3%)在家中,20例(12.2%)在专业护理机构。

证据类型、等级与局限

  • 证据类型:回顾性随访队列研究。
  • 作者认为超过90天的长期照护支持(包括气管切开)似乎有益,值得进一步研究。

对床旁实践的改变

  • 作者认为超过90天的长期照护支持(包括气管切开)似乎有益,值得进一步研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the disease it causes (COVID-19) have resulted in an increase in critical illness and in the prevalence of acute respiratory failure with the need for tracheostomy. The characteristics and long-term outcomes of this patient cohort are not well identified.

RESEARCH QUESTION: What are the characteristics of patients who develop the need for tracheostomy due to SARS-CoV-2 with acute respiratory distress syndrome (ARDS)? What is their 90-day and 1-year survival and are there any identifiable risk factors for mortality and ventilator dependency?

STUDY DESIGN AND METHODS: Retrospective, follow-up cohort study of adult patients with COVID-19 infection and ARDS who required tracheostomy placement in a large healthcare system.

RESULTS: One hundred sixty-four consecutive patients with SARS-CoV-2 admitted to ICUs for ARDS who required tracheostomy placement between March 2020 and March 2021 were identified. One hundred nine (66.5%) were male. Average age was 63.5 years. The most common comorbidities were obesity, hypertension, diabetes mellitus, congestive heart failure, chronic kidney disease, chronic obstructive pulmonary disease (COPD), atrial fibrillation, and asthma. The most common complications during hospitalization were delirium, secondary infections, acute kidney injury, pneumothorax, and venous thromboembolism. Ninety-day and 1-year mortality were 29.9% and 44.5%, respectively. Ninety-six patients (58.5%) were liberated from the ventilator, and 84 (51.2%) had the tracheostomy tube decannulated. Asthma, COPD, atrial fibrillation, and renal replacement therapy requirement in the ICU correlated with increased risk of ventilator dependency. Among survivors at 1 year, 71 patients (43.3%) were residing at home and 20 patients (12.2%) remained in a skilled nursing facility.

INTERPRETATION: COVID-19 has resulted in a significant burden of acute critical illness and acute respiratory failure with the need for tracheostomy. A significant percentage of patients with SARS-CoV-2 requiring tracheostomy were alive and at home 1 year after tracheostomy placement. Long-term care support, including tracheostomy, beyond 90 days appears to be beneficial in this patient population and warrants further investigation.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Abunasser JJ, Perez O, Wang X, et al. One-Year Outcomes of Patients Requiring Tracheostomy Placement Due to Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Crit Care Explor. 2023. PMID: 37546232. doi:10.1097/CCE.0000000000000951

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。